Wisr originated more than $29 million in new loans during H1FY2019, up 437% on H1FY2018. From this around $27.7m was onsold to institutional investors therefore their loan assets available for sale will have increased by around $1.3m. This is an important point as while the cash balance dropped by $2.26m this quarter the loan assets will have increased by around $1.2m meaning that the true cash burn has reduced from around 1.2m last quarter to around 1m this quarter. With revenue generation gaining momentum and costs having flat lined/dropped the burn by mid year I believe will getting very close to zero/CFP. This of course assume they continue to achieve such strong growth.
Unaudited half-yearly (H1FY19) revenue was increased 56%, up to $1.2 million (H1FY18:$759k). FY18 total revenue was $1.6m, given the acceleration in growth rate my expectation is that for H2FY19 the revenue will exceed the FY18 full year revenue so over $1.6m which would set a full year target around $2.8m. With the last HY revenue growth being 56% then that would give a target of $1.87m setting a full year target of over $3m revenue
- Forums
- ASX - By Stock
- WZR
- WZR Significantly Undervalued vs Market Leader
WZR Significantly Undervalued vs Market Leader, page-8
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WZR (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.9¢ |
Change
0.002(7.41%) |
Mkt cap ! $41.41M |
Open | High | Low | Value | Volume |
2.6¢ | 2.9¢ | 2.5¢ | $140.4K | 5.401M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1801700 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 27197 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 750032 | 0.028 |
2 | 275337 | 0.027 |
1 | 100000 | 0.026 |
2 | 113413 | 0.025 |
1 | 40000 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 399859 | 2 |
0.030 | 2464893 | 5 |
0.031 | 300000 | 1 |
0.033 | 3257 | 1 |
0.034 | 267613 | 2 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
WZR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online